2023 annual financial data

Cytosorbents 2023 Financial results

Direct answer

Revenue was 31,084,953 USD.

Operating income was -31,948,620 USD and net income was -29,246,760 USD.
Operating cash flow was -21,655,136 USD.

Get free Cytosorbents email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
31,084,953 USD
Operating income
-31,948,620 USD
Net income
-29,246,760 USD
Operating cash flow
-21,655,136 USD